Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
J&J reports promising results for new psoriasis drug, potentially offering oral treatment option.
Johnson & Johnson has reported positive results from a late-stage study of their new oral drug for psoriasis, showing significant improvements in skin clearance for patients with plaque psoriasis.
The drug is a collaboration between J&J and Protagonist.
If approved, it could offer a new treatment option for those suffering from the skin condition.
3 Articles
J&J informa de resultados prometedores para un nuevo medicamento para la psoriasis, que potencialmente ofrece una opción de tratamiento oral.